Whiteside Darcy, McLeod Ross, Graham Gail, Steckley Jamie L, Booth Karen, Somerville Martin J, Andrew Susan E
Department of Medical Genetics, University of Alberta, Edmonton, Alberta, T6G 2H7 Canada.
Cancer Res. 2002 Jan 15;62(2):359-62.
Individuals with a germ-line mutation in one of the DNA mismatch repair (MMR) genes are at significant risk for colorectal cancer and other tumors. Three families have previously been reported with individuals homozygous for mutations in the MMR gene MLH1 that are predicted to compromise MMR. These individuals develop hematological malignancies and/or neurofibromatosis type 1 at an early age. Here, in an individual, we demonstrate that a homozygous novel mutation in the MMR gene MSH2 is associated with leukemia and multiple café-au-lait spots, a feature of neurofibromatosis type 1. Because the hematological malignancies observed in the individuals homozygous for the loss of MMR are reflective of the lymphomas seen in mice lacking MMR, the mice may provide a useful model for human neoplasia.
DNA错配修复(MMR)基因之一发生种系突变的个体患结直肠癌和其他肿瘤的风险很高。此前已有三个家庭被报道,其成员中MMR基因MLH1发生纯合突变,预计会损害MMR功能。这些个体在早年就会发生血液系统恶性肿瘤和/或1型神经纤维瘤病。在此,我们在一名个体中证明,MMR基因MSH2中的纯合新突变与白血病和多个咖啡牛奶斑有关,这是1型神经纤维瘤病的一个特征。由于在MMR缺失的纯合个体中观察到的血液系统恶性肿瘤与缺乏MMR的小鼠中出现的淋巴瘤相似,因此这些小鼠可能为人类肿瘤形成提供一个有用的模型。